Try our Advanced Search for more refined results

October 28, 2016

United States of America ex rel. v. Janssen Biotech, Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 01, 2026

    Janssen Biotech Beats Kickback Suit Over Advice To Docs

    A Massachusetts federal judge has dismissed a False Claims Act case against Janssen Biotech Inc., saying a "large evidentiary hole" sunk a whistleblower's claims that the drug company provided kickbacks to doctors in the form of free consulting services.

6 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login